Albert DaCosta'un ücretlendirmesi Paragon 28'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	-US$56m
Jun 30 2024	n/a	n/a	-US$55m
Mar 31 2024	n/a	n/a	-US$54m
Dec 31 2023	US$3m	US$701k	-US$48m
Sep 30 2023	n/a	n/a	-US$74m
Jun 30 2023	n/a	n/a	-US$73m
Mar 31 2023	n/a	n/a	-US$69m
Dec 31 2022	US$5m	US$650k	-US$67m
Sep 30 2022	n/a	n/a	-US$33m
Jun 30 2022	n/a	n/a	-US$29m
Mar 31 2022	n/a	n/a	-US$22m
Dec 31 2021	US$5m	US$615k	-US$14m
Sep 30 2021	n/a	n/a	-US$5m
Jun 30 2021	n/a	n/a	US$4m
Mar 31 2021	n/a	n/a	US$4m
Dec 31 2020	US$933k	US$588k	US$3m

Tazminat ve Piyasa: Albert 'ın toplam tazminatı ($USD 3.23M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 3.21M ).

Tazminat ve Kazançlar: Albert 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Albert DaCosta (51 yo)

13yrs

Görev süresi

US$3,232,421

Tazminat

Mr. Albert DaCosta is Co-Founder of Paragon 28, Inc. and serves as Chief Executive Officer, President and Director since 2012. Mr. DaCosta is a veteran in the foot and ankle industry with over 18 years of...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Albert DaCosta	Co-Founder	13yrs	US$3.23m	13.26% $ 119.4m
Robert McCormack	General Counsel & Secretary	1.4yrs	US$1.40m	0.0092% $ 83.1k
Matthew Jarboe	Executive VP of Sales & Chief Commercial Officer	7yrs	US$1.53m	0.27% $ 2.5m
Andrew Hill	Executive Vice President of Research & Development	1.3yrs	US$1.31m	0.091% $ 823.3k
Chadi Chahine	CFO & Executive VP of Supply Chain Operations	less than a year	Veri yok	0.00040% $ 3.6k
Matthew Brinckman	Senior Vice President of Strategy & Investor Relations	2.4yrs	Veri yok	Veri yok
Brendan Shook	Executive VP of Marketing & Medical Education	5.3yrs	Veri yok	Veri yok
Matthew Millard	Chief Human Resources Officer	1.8yrs	Veri yok	Veri yok
John Shumaker	Executive Vice President of Sales - U.S.	4yrs	Veri yok	Veri yok
Hans Kestler	Executive Vice President of International	4.5yrs	Veri yok	Veri yok
Yuliya Aslan	Senior Vice President of IT	4yrs	Veri yok	Veri yok
Sanket Shah	Senior VP	1.3yrs	Veri yok	Veri yok

3.2yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim: FNA 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.2 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Albert DaCosta	Co-Founder	13yrs	US$3.23m	13.26% $ 119.4m
David Demski	Independent Director	less than a year	Veri yok	0.048% $ 431.5k
B. Johnson	Independent Director	3.1yrs	US$212.50k	0.032% $ 287.5k
Stephen Newman Oesterle	Independent Director	4yrs	US$210.00k	0.029% $ 261.6k
Thomas Schnettler	Lead Independent Director	4.5yrs	US$245.00k	0.027% $ 246.2k
Quentin Blackford	Independent Director	2.4yrs	US$220.00k	0.028% $ 256.0k
Meghan Scanlon	Independent Director	2.8yrs	US$210.61k	0.024% $ 218.0k
Alf Grunwald	Independent Director	7.9yrs	US$210.00k	0.036% $ 320.4k
Kristina Wright	Director	3.1yrs	US$220.00k	0.019% $ 174.4k

3.1yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: FNA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.1 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/01/07 05:57
Gün Sonu Hisse Fiyatı	2025/01/07 00:00
Kazançlar	2024/09/30
Yıllık Kazançlar	2023/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

Paragon 28, Inc. 10 Bu analistlerden 7, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Craig Bijou	BofA Global Research
Neil Chatterji	B. Riley Securities, Inc.
Caitlin Cronin	Canaccord Genuity

Paragon 28 Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Co-Founder exercised options and sold US$301k worth of stock

Paragon 28, Inc. Appoints Dave Demski to Board of Directors

Paragon 28, Inc., Annual General Meeting, May 17, 2024

Paragon 28, Inc. Announces Chief Financial Officer Changes

Co-Founder recently bought US$255k worth of stock

Jason Edie Step Down from the Position of Chief Technology Officer of Paragon 28, Inc

Recent updates

Co-Founder exercised options and sold US$301k worth of stock

Is Paragon 28 (NYSE:FNA) Using Too Much Debt?

Paragon 28, Inc. Appoints Dave Demski to Board of Directors

Analysts Have Made A Financial Statement On Paragon 28, Inc.'s (NYSE:FNA) Third-Quarter Report

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Paragon 28, Inc. Raises Net Revenue Guidance for 2024

Bronstein, Gewirtz & Grossman, LLC Files Class Action Lawsuit Against Paragon 28, Inc

Johnson Fistel, LLP Announces Class Action Lawsuit Commencement on Behalf of Investors of Paragon 28, Inc

Paragon 28, Inc. to Report Q3, 2024 Results on Nov 12, 2024

Paragon 28, Inc. Launches the Phantom® Fibula Nail System for Less Invasive Fracture Repair

It's Down 28% But Paragon 28, Inc. (NYSE:FNA) Could Be Riskier Than It Looks

Rosen Law Firm Files Securities Class Action Lawsuit Against Paragon 28, Inc

We Think Paragon 28 (NYSE:FNA) Has A Fair Chunk Of Debt

Paragon 28, Inc. Launches the R3FLEX™? Stabilization System to Anatomically Repair Ankle Syndesmotic In Injury

Consensus EPS estimates fall by 13%

Paragon 28, Inc. Announces the Launch of SMART28 Case Management Portal

Paragon 28, Inc. Updates Revenue Guidance for the Full Year of 2024

Paragon 28, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Investors Give Paragon 28, Inc. (NYSE:FNA) Shares A 27% Hiding

Is Paragon 28 (NYSE:FNA) Using Too Much Debt?

Consensus EPS estimates fall by 32%

Price target decreased by 11% to US$16.00

Paragon 28, Inc. Reaffirms Revenue Guidance for the Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Many Still Looking Away From Paragon 28, Inc. (NYSE:FNA)

Paragon 28, Inc., Annual General Meeting, May 17, 2024

Paragon 28, Inc. to Report Q1, 2024 Results on May 08, 2024

New minor risk - Share price stability

Paragon 28, Inc. Announces Chief Financial Officer Changes

Paragon 28, Inc. Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler®? R3INFORCE™? Extraosseous Repair System

New major risk - Financial position

Co-Founder recently bought US$255k worth of stock

Consensus EPS estimates fall by 24%

Paragon 28, Inc. (NYSE:FNA) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Full year 2023 earnings: EPS misses analyst expectations

Paragon 28, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Paragon 28, Inc. to Report Q4, 2023 Results on Feb 29, 2024

Paragon 28, Inc. Launches Precision®? Mis Bunion System Offering Surgeons A Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions

Paragon 28, Inc. Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures

New minor risk - Shareholder dilution

Paragon 28, Inc. Launches the Mister Tendon™ Harvester System – the First and Only Minimally Invasive Harvesting System for Fhl and Fdl Tendon Transfer Procedures

Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures

Paragon 28, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023

Paragon 28, Inc. Announce the Launch of the Grappler Knotless Anchor System and Bridgeline Tape

After Leaping 29% Paragon 28, Inc. (NYSE:FNA) Shares Are Not Flying Under The Radar

Paragon 28, Inc. Launches Beast Cortical Fibers

Third quarter 2023 earnings released: US$0.10 loss per share (vs US$0.13 loss in 3Q 2022)

Paragon 28, Inc. Reaffirms Revenue Guidance for the Year 2023

Price target decreased by 8.4% to US$25.00

Paragon 28, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Paragon 28®, Inc. Receives FDA Approval for Ide Feasibility Study of Its Smart Total Talus™ System for Use in Conjunction with the Apex 3D™ Total Ankle Replacement System

New minor risk - Financial position

Second quarter 2023 earnings released: US$0.13 loss per share (vs US$0.13 loss in 2Q 2022)

Paragon 28, Inc. to Report Q2, 2023 Results on Aug 02, 2023

Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System

Jason Edie Step Down from the Position of Chief Technology Officer of Paragon 28, Inc

Paragon 28, Inc. Provides Revenue Guidance for the Year 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 30%

Full year 2022 earnings: EPS misses analyst expectations

Paragon 28, Inc. to Report Q4, 2022 Results on Mar 02, 2023

Paragon 28, Inc. has completed a Follow-on Equity Offering in the amount of $110.5 million.

Paragon 28 announces public offering of 6.5M shares

Paragon 28, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full-Year Ended December 31, 2022

Paragon 28 guides Q4 and FY22 revenue outlook above consensus

Chief Commercial Officer exercised options and sold US$1.8m worth of stock

Paragon 28, Inc. Enters Settlement Agreement with Stryker Corp

Consensus forecasts updated

Insider recently sold US$1.1m worth of stock